Breaking down acronyms with the experts who work with them day in and day out
March 25, 2019

Karen Leighton, Director of CTRL, helps QualTex Laboratories with overseeing customized testing for customer industries and cellular therapy clients. She answers the question “What is CTRL?”

What is CTRL?

CTRL is the Cell and Tissue Reference Lab and a part of QualTex Laboratories. It is comprised of the Microbiology and Confirmatory labs, with a Cellular Therapy Testing lab in development.

Our multi-purpose lab of 17 employees performs a series of tests that include:

Breaking down acronyms with the experts who work with them day in and day out
March 18, 2019

Scott Jones, Vice President of Scientific Affairs, helps BioBridge Global and its subsidiaries ensure R&D (research and development) develops processes and products that generate business opportunities. He answers the basic question – “What is R&D?”

What is R&D?

The “R” in R&D stands for research, and the “D” stands for development. BBG uses basic and applied research to discover a solution to a problem or create a new product. We perform the appropriate work and processes for the solution or new product. 

Our focus is to take knowledge or technologies from the scientific community and apply them to solve problems or develop new products at BBG. Here at BBG, we perform more development than research, and the form of research we focus on is applied research rather than basic research.

The R&D process involves multiple steps:

March 11, 2019

Tim Blonkvist, architect with Overland Partners, recently visited BioBridge Global and talked with Belinda Flores, Director, Customer Relationship Management in STBTC, about the development of the organization’s art collection.

Overland Partners designed what is now known as the Headquarters Building in 1994.

March 5, 2019

A patient in England reportedly has been cured of infection with HIV, the virus that causes AIDS, via a stem cell transplant.

The case, which was reported in the journal Nature and made news around the world, is just the second instance in which a patient’s body has been cleared of the virus. The researchers referred to it as long-term remission, but some experts say it is a cure.

The first case of complete clearing of HIV from the body occurred 12 years ago, in much the same way. The most recent patient, who has not been identified, underwent treatment for Hodgkin lymphoma, and in the process received a stem cell transplant in May 2016.

March 4, 2019

Two regenerative medicine guidance documents drafted last year have now been published by the U.S. Food and Drug Administration. The documents clarify new considerations on the development and review of regenerative medicine therapies.

The first guidance deals with the evaluation of devices used with regenerative medicine advanced therapies. The second guidance covers expedited programs for regenerative medicine therapies for serious conditions.